Clinical Trial Update: An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). [Phase 3]

View source ↗

Summary

Phase 3 Italian study evaluating the efficacy of atomoxetine for children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositiona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Oppositional Defiant Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-01-18